https://www.selleckchem.com/products/ABT-263.html
Rapidly progressive interstitial lung disease (RP-ILD) in dermatomyositis (DM) patients positive for anti-melanoma differentiation-associated gene 5 (anti-MDA5) autoantibody (MDA5-DM) often have poor prognosis, frequently fatal. As there is a scarcity of data regarding the effect of intravenous immunoglobulin (IVIG) on RP-ILD in MDA5-DM patients (MDA5-RPILD), we conducted this study to determine the efficacy of a IVIG add-on initial treatment. Patients with newly-onset MDA5-RPILD from September 2018 to June 2020 were retrospectively rev
Aimer
Commentaire
Partagez
